Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00403195
: November 23, 2006
Last Update Posted
: September 10, 2012
Glostrup University Hospital, Copenhagen
University Hospital, Gentofte, Copenhagen
Information provided by (Responsible Party):
Peter Kofoed, Glostrup University Hospital, Copenhagen
The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.
Condition or disease
Retinal DegenerationDiabetic Retinopathy
The disease Ocular Ischemic Syndrome (OIS) is not a well described entity. It occurs after a long-standing period of extremely low blood supply to the retina caused by atherosclerosis of the carotid arteries. In this study we will analyze why OIS is developed in some patients and not developed in others. The patients with OIS will be thorough examined and will be compared with 1) a control group of healthy people and 2) with control group of patients with diabetic retinopathy. Furthermore the impact of vascular surgery on OIS will be analyzed.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with the disease ocular ishemic syndrome. Patients will be screened through vascular surgery departments.